obesity drug news today glp-1 2025 sep 30 Market Size to Hit USD 66.57 Billion by 2035 GLP-1 Pharmacy Pricing Update (Dec

First thing in the morning, ideally 30 minutes before your first meal

Eur J Med Chem

The DURATION-8 trial (N=695) evaluated exenatide once weekly plus dapagliflozin and found additive HbA1c reduction (1.5% versus 1.0% for either monotherapy) without increased hypoglycemia [15]

Because of these broad effects, we wanted to see whether they would reduce all-cause mortality compared with another more weight-neutral diabetes medication. Mavromatis and colleagues conducted an observational study in which they used the Optum database to identify 170,030 adults (mean age, 56.8 years

Retatrutide Explained: How the Triple Agonist Actually Works What Is Retatrutide